Skip to main content
OpenTrials
Completed

NCT Number: NCT00768573

Taste Test of a New Formulation of Sildenafil (Revatio)

taste of formulation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

None Volunteer

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pfizer Investigational Site

Cambridge, Massachusetts, 02140, United States

About this study

taste test None

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy

Exclusion criteria

  • History of hypersensitivity to test compounds or excipients.

Treatment and study plan

Sildenafil

Drug

Oral suspension of sildenafil.

Primary outcomes

  1. palatability (aroma, flavour texture and mouth feel)

    Time frame: Duration of study.

Sponsors and collaborators

Lead sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Industry

Registry information

Official study title

A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Oct 8, 2008
Registry last updated
Feb 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.